Gli2 Is Targeted for Ubiquitination and Degradation by β-TrCP Ubiquitin Ligase*
By N. Bhatia, S. Thiyagarajan, Irina A. Elcheva, M. Saleem, A. Dlugosz, H. Mukhtar, V. Spiegelman. Journal of Biological Chemistry, 2006
130 citations recorded by the source corpus.
The Hedgehog (Hh) signaling pathway plays a crucial role in embryogenesis and has been linked to the development of several human malignancies. The transcription factor Gli2 plays a key role in the transduction of Hh signals by modulating transcription of some Hh target genes, yet the mechanisms that control Gli2 protein expression are largely unknown. Here we report that β-transducin repeat-containing protein (β-TrCP) E3 ubiquitin ligase is required for Gli2 degradation. β-TrCP2 directly binds wild type Gli2 and promotes its ubiquitination. Single amino acid substitution in Gli2 putative binding site inhibits its interaction with β-TrCP2, its ubiquitination, and stabilizes the Gli2 protein. Stable Gli2 mutant is expressed in higher levels and is more potent in the activation of Gli-dependent transcription as compared with wild type Gli2. We also found that GLI2 protein is expressed highly in prostate cancer cell lines and primary tumors, whereas the level of GLI2 mRNA is not appreciably different in normal and neoplastic prostate. These data identify β-TrCP2 as a pivotal regulator of Gli2 expression and point to an important role for posttranslational modulation of GLI2 protein levels in Hh pathway-associated human prostate cancer.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/7cfac7827291c32ef4fa644b02d4c829962e2465
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
Citations in the corpus
- Post-Translational Modifications That Drive Prostate Cancer Progression (2021, background): “(Component of) E3 Ligase Description Affected Protein(s) and/or Signaling Pathways Effects on Processes TRAF6 RING domain E3 ubiquitin ligase p85a [208]; TGFβ type I receptor [209,210]; PS1 [210]; mTOR [211]; AKT [196]; TAK1 [212]; EZH2 [190] PI3K/AKT signaling; migration [208]; tumor-promoting effe”